BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26959126)

  • 1. Stem Cell-Based Therapy for Diseases of the Retinal Pigment Epithelium: From Bench to Bedside.
    Sachdeva MM; Eliott D
    Semin Ophthalmol; 2016; 31(1-2):25-9. PubMed ID: 26959126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.
    Schwartz SD; Regillo CD; Lam BL; Eliott D; Rosenfeld PJ; Gregori NZ; Hubschman JP; Davis JL; Heilwell G; Spirn M; Maguire J; Gay R; Bateman J; Ostrick RM; Morris D; Vincent M; Anglade E; Del Priore LV; Lanza R
    Lancet; 2015 Feb; 385(9967):509-16. PubMed ID: 25458728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
    Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
    Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy.
    Petrus-Reurer S; Bartuma H; Aronsson M; Westman S; Lanner F; Kvanta A
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration.
    Mehat MS; Sundaram V; Ripamonti C; Robson AG; Smith AJ; Borooah S; Robinson M; Rosenthal AN; Innes W; Weleber RG; Lee RWJ; Crossland M; Rubin GS; Dhillon B; Steel DHW; Anglade E; Lanza RP; Ali RR; Michaelides M; Bainbridge JWB
    Ophthalmology; 2018 Nov; 125(11):1765-1775. PubMed ID: 29884405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics.
    Hinkle JW; Mahmoudzadeh R; Kuriyan AE
    Stem Cell Res Ther; 2021 Oct; 12(1):538. PubMed ID: 34635174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration.
    Kashani AH; Lebkowski JS; Rahhal FM; Avery RL; Salehi-Had H; Dang W; Lin CM; Mitra D; Zhu D; Thomas BB; Hikita ST; Pennington BO; Johnson LV; Clegg DO; Hinton DR; Humayun MS
    Sci Transl Med; 2018 Apr; 10(435):. PubMed ID: 29618560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.
    da Cruz L; Fynes K; Georgiadis O; Kerby J; Luo YH; Ahmado A; Vernon A; Daniels JT; Nommiste B; Hasan SM; Gooljar SB; Carr AF; Vugler A; Ramsden CM; Bictash M; Fenster M; Steer J; Harbinson T; Wilbrey A; Tufail A; Feng G; Whitlock M; Robson AG; Holder GE; Sagoo MS; Loudon PT; Whiting P; Coffey PJ
    Nat Biotechnol; 2018 Apr; 36(4):328-337. PubMed ID: 29553577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Preclinical Safety Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells for Macular Degeneration.
    Mazzilli JL; Snook JD; Simmons K; Domozhirov AY; Garcia CA; Wetsel RA; Zsigmond EM; Westenskow PD
    J Ocul Pharmacol Ther; 2020; 36(1):65-69. PubMed ID: 31596637
    [No Abstract]   [Full Text] [Related]  

  • 10. Embryonic stem cell trials for macular degeneration: a preliminary report.
    Schwartz SD; Hubschman JP; Heilwell G; Franco-Cardenas V; Pan CK; Ostrick RM; Mickunas E; Gay R; Klimanskaya I; Lanza R
    Lancet; 2012 Feb; 379(9817):713-20. PubMed ID: 22281388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Age-Related Macular Degeneration with Pluripotent Stem Cell-Derived Retinal Pigment Epithelium.
    Vitillo L; Tovell VE; Coffey P
    Curr Eye Res; 2020 Mar; 45(3):361-371. PubMed ID: 31777296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I clinical trial of human embryonic stem cell-derived retinal pigment epithelial cells for early-stage Stargardt macular degeneration: 5-years' follow-up.
    Li SY; Liu Y; Wang L; Wang F; Zhao TT; Li QY; Xu HW; Meng XH; Hao J; Zhou Q; Wang L; Yin ZQ
    Cell Prolif; 2021 Sep; 54(9):e13100. PubMed ID: 34347352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suprachoroidal Adipose Tissue-Derived Mesenchymal Stem Cell Implantation in Patients with Dry-Type Age-Related Macular Degeneration and Stargardt's Macular Dystrophy: 6-Month Follow-Up Results of a Phase 2 Study.
    Oner A; Gonen ZB; Sevim DG; Smim Kahraman N; Unlu M
    Cell Reprogram; 2018 Dec; 20(6):329-336. PubMed ID: 31251672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langmuir-Schaefer film deposition onto honeycomb porous films for retinal tissue engineering.
    Calejo MT; Ilmarinen T; Vuorimaa-Laukkanen E; Talvitie E; Hakola HM; Skottman H; Kellomäki M
    Acta Biomater; 2017 May; 54():138-149. PubMed ID: 28223209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subretinal implantation of a monolayer of human embryonic stem cell-derived retinal pigment epithelium: a feasibility and safety study in Yucatán minipigs.
    Koss MJ; Falabella P; Stefanini FR; Pfister M; Thomas BB; Kashani AH; Brant R; Zhu D; Clegg DO; Hinton DR; Humayun MS
    Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1553-1565. PubMed ID: 27335025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients.
    Song WK; Park KM; Kim HJ; Lee JH; Choi J; Chong SY; Shim SH; Del Priore LV; Lanza R
    Stem Cell Reports; 2015 May; 4(5):860-72. PubMed ID: 25937371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration.
    Lu B; Malcuit C; Wang S; Girman S; Francis P; Lemieux L; Lanza R; Lund R
    Stem Cells; 2009 Sep; 27(9):2126-35. PubMed ID: 19521979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the cAMP and Transforming Growth Factor-β Pathway Increases Proliferation to Promote Re-Epithelialization of Human Stem Cell-Derived Retinal Pigment Epithelium.
    Choudhary P; Gutteridge A; Impey E; Storer RI; Owen RM; Whiting PJ; Bictash M; Benn CL
    Stem Cells Transl Med; 2016 Jul; 5(7):925-37. PubMed ID: 27112176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell culture models to study retinal pigment epithelium-related pathogenesis in age-related macular degeneration.
    Bharti K; den Hollander AI; Lakkaraju A; Sinha D; Williams DS; Finnemann SC; Bowes-Rickman C; Malek G; D'Amore PA
    Exp Eye Res; 2022 Sep; 222():109170. PubMed ID: 35835183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients.
    Sung Y; Lee MJ; Choi J; Jung SY; Chong SY; Sung JH; Shim SH; Song WK
    Br J Ophthalmol; 2021 Jun; 105(6):829-837. PubMed ID: 32727729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.